Essex Bio-Technology Limited (HKG:1061)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.330
+0.100 (3.10%)
Apr 24, 2026, 3:59 PM HKT

Essex Bio-Technology Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,8882,1381,6671,4132,4012,848
Market Cap Growth
-14.62%28.20%17.98%-41.13%-15.72%15.63%
Enterprise Value
1,4511,7861,3941,3492,2722,753
Last Close Price
3.333.772.862.323.834.41
PE Ratio
5.946.725.435.1310.658.23
Forward PE
5.843.143.143.626.397.95
PS Ratio
1.041.181.000.811.821.74
PB Ratio
0.780.890.790.741.391.64
P/TBV Ratio
1.351.531.411.362.732.64
P/FCF Ratio
9.5010.755.154.448.198.93
P/OCF Ratio
6.166.984.534.176.276.96
PEG Ratio
-0.660.660.660.660.66
EV/Sales Ratio
0.800.990.840.781.721.68
EV/EBITDA Ratio
3.063.823.483.356.766.57
EV/EBIT Ratio
3.484.293.933.847.526.99
EV/FCF Ratio
7.308.984.304.247.758.63
Debt / Equity Ratio
0.140.140.090.150.280.33
Debt / EBITDA Ratio
0.730.730.460.721.451.34
Debt / FCF Ratio
1.751.750.580.921.671.77
Net Debt / Equity Ratio
-0.18-0.18-0.18-0.11-0.03-0.06
Net Debt / EBITDA Ratio
-0.93-0.93-0.93-0.55-0.16-0.25
Net Debt / FCF Ratio
-2.20-2.20-1.15-0.69-0.18-0.33
Asset Turnover
0.560.560.570.630.470.62
Inventory Turnover
2.082.082.142.071.341.83
Quick Ratio
1.921.921.621.371.811.95
Current Ratio
2.112.111.811.542.162.24
Return on Equity (ROE)
14.02%14.02%15.18%15.06%13.01%21.89%
Return on Assets (ROA)
8.05%8.05%7.63%7.93%6.77%9.31%
Return on Invested Capital (ROIC)
16.18%17.16%16.81%16.55%15.82%22.89%
Return on Capital Employed (ROCE)
15.30%15.30%15.60%17.40%14.00%18.10%
Earnings Yield
16.85%14.88%18.43%19.48%9.39%12.15%
FCF Yield
10.53%9.30%19.44%22.51%12.22%11.20%
Dividend Yield
4.33%3.71%4.19%3.88%1.70%2.16%
Payout Ratio
23.17%23.17%19.39%14.50%24.19%15.00%
Buyback Yield / Dilution
2.63%2.63%2.24%0.62%0.43%0.21%
Total Shareholder Return
6.88%6.34%6.43%4.50%2.13%2.37%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.